Dorothea Ledergerber

Dorothea is a pharmacist with more than 20 years of experience in research, development, manufacturing and supply of pharmaceutical products. She received her PhD from the University of the Saarland, Saarbrücken, Germany.

While with Novartis, she was leading manufacturing sites in Switzerland, Germany and
Ireland. A highlight in her career was the build-up and operational launch of the first
commercial Cell & Gene manufacturing facility for Novartis in Europe.

In 2020, Dorothea moved on to Tigen Pharma, a Swiss biotech company in the field of cell
therapies to cure cancer. Tigen is a disruptive catalyst, combining a unique culture with a
multidisciplinary set of clinical and technical capabilities and a long-term perspective to the
benefit of patients and society.

Dorothea is a firm believer in cross-cultural and -functional teams to go beyond the beaten
industry track.